Innogenetics has announced the implementation of its restructuring plan for the pharma division of GENimmune.
Subscribe to our email newsletter
Based on the collective labor agreement signed on May 8, 2008 with its social partners, a total of 24 labor contracts will be terminated in a first phase procedure effective June 1, 2008.
On June 1, 2008 the biologicals production unit will be re-integrated into Innogenetics under the name Innogenetics Biologicals.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.